Following this conceptual framework, we aimed to evaluate the effects of CB2 and TRPV1 stimulation with their selective agonists, JWH-133 and RTX respectively, on macrophages isolated from SCD pediatric and young adults patients, assessing their effects after 24 h of incubation. Here, TRPV1 is linked to Schnyder corneal dystrophy.